Also trades as: MSCL.TO (TSX) · $vol 0M · MSCLF (OTC) · $vol 0M · MSCL.V (TSXV) · $vol 0M

$8.50

+0.00 (+0.00%)

Weekly Expected Move ±7.4%

$7 $8 $8 $9 $10

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 36 · $11.0M mcap · 1M float · 4.95% daily turnover · Short 52% of daily vol

View Full Income Statement

No data available

Line Item	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$0	$0	$0	$0
Cost of Revenue	$0	$1K	$0	$975
Gross Profit	$0	-$1K	$0	-$974
Gross Margin	—	—	—	—
R&D Expenses	$4M	$5M	$7M	$9M
SG&A Expenses	$2M	$2M	$2M	$3M
Operating Expenses	$6M	$8M	$10M	$12M
Operating Income	-$6M	-$8M	-$10M	-$12M
Operating Margin	—	—	—	—
Interest Expense	$0	$0	$0	$0
Income Before Tax	-$6M	-$7M	-$10M	-$11M
Tax Expense	$19K	$58K	$33K	$43K
Net Income	-$6M	-$7M	-$10M	-$11M
Net Margin	—	—	—	—
EPS (Diluted)	$-0.36	$-0.48	$-0.53	$-0.55
EBITDA	-$6M	-$8M	-$10M	-$12M
Shares Outstanding	14M	15M	18M	21M

MSLE NASDAQ